Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans

被引:21
作者
Heinen, C. [1 ]
Reuss, S. [2 ]
Saaler-Reinhardt, S. [3 ]
Langguth, P. [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Technol & Biopharmaceut, D-55128 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55128 Mainz, Germany
[3] KHS Pharma Holding GmbH, Ingelheim, Germany
关键词
Permeation; Mucoadhesion; Ussing chamber; Intestinal loop; Polyelectrolyte complexes; Trospium chloride; POLYMERIC ABSORPTION ENHANCER; ZONULA OCCLUDENS TOXIN; ORAL PROTEIN DELIVERY; IN-VITRO; TROSPIUM CHLORIDE; INTESTINAL-ABSORPTION; CHITOSAN DERIVATIVES; PERORAL DELIVERY; MUCOADHESIVE; PERMEABILITY;
D O I
10.1016/j.ejpb.2013.03.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to investigate the potential of lambda-carrageenan to work as an absorption modifying excipient in combination with formulations of BCS class 3 substances. Trospium chloride was used as a model BCS class 3 substance. Polyelectrolyte complexes of trospium and lambda-carrageenan were produced by layer-by-layer complexation. A lambda-carrageenan-containing formulation was administered either in capsules size 9 to rats by gavage or directly into ligated intestinal loops of rats. Exceptionally strong variations were observed in the plasma concentrations of the rats that received lambda-carrageenan compared to the control group, but enhanced plasma concentrations were observed only in some of the rats. In vitro permeability studies were performed across Caco2-monolayers and across excised segments of rat jejunum in a modified Ussing chamber to learn more about the mechanism of absorption enhancement. The complex did not show any effect in Caco2-cells, but led to a major enhancement of permeability across excised segments in modified Ussing chambers. Carrageenan did not lead to alterations of tight junctions. The bioavailability enhancing effect thus was most likely due to an interaction of the polyelectrolyte-drug complex with the mucus, which provided an intimate contact between the drug and the absorbing surface. A similar effect was also achievable with other types of carrageenan and was also transferable to other compounds. In conclusion, lambda-carrageenan-drug complexes show interesting excipient-drug-epithelium interactions - however, for full utilization of the permeation enhancing potential, an intimate and reproducible contact between absorbing epithelia and the complex is needed. (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 33
页数:8
相关论文
共 39 条
[1]  
Acarturk Fusun, 2009, Recent Pat Drug Deliv Formul, V3, P193
[2]   Strategies to Prolong the Intravaginal Residence Time of Drug Delivery Systems [J].
Baloglu, Esra ;
Senyigit, Zeynep Ay ;
Karavana, Sinem Y. ;
Bernkop-Schnuerch, Andreas .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2009, 12 (03) :312-336
[3]   Polyelectrolyte-Drug Complexes of Lambda Carrageenan and Basic Drugs: Relevance of Particle Size and Moisture Content on Compaction and Drug Release Behavior [J].
Bonferoni, M. C. ;
Sandri, G. ;
Rossi, S. ;
Ferrari, F. ;
Caramella, C. ;
Aguzzi, C. ;
Viseras, C. .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2008, 34 (11) :1188-1195
[4]   Carrageenan-gelatin mucoadhesive systems for ion-exchange based ophthalmic delivery: in vitro and preliminary in vivo studies [J].
Bonferoni, MC ;
Chetoni, P ;
Giunchedi, P ;
Rossi, S ;
Ferrari, F ;
Burgalassi, S ;
Caramella, C .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (03) :465-472
[5]  
Cano-Cebrian Maria Jose, 2005, Current Drug Delivery, V2, P9, DOI 10.2174/1567201052772834
[6]   Characterization of polyelectrolyte complexes between chondroitin sulfate and chitosan in the solid state [J].
Chen, WB ;
Wang, LF ;
Chen, JS ;
Fan, SY .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2005, 75A (01) :128-137
[7]   Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery [J].
Chopra, Shruti ;
Mahdi, Saiqa ;
Kaur, Jasjeet ;
Iqbal, Zeenat ;
Talegaonkar, Sushma ;
Ahmad, Farhan J. .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (08) :1021-1032
[8]   The role of glutathione in the permeation enhancing effect of thiolated polymers [J].
Clausen, AE ;
Kast, CE ;
Bernkop-Schnürch, A .
PHARMACEUTICAL RESEARCH, 2002, 19 (05) :602-608
[9]   Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin [J].
Cox, DS ;
Raje, S ;
Gao, HL ;
Salama, NN ;
Eddington, ND .
PHARMACEUTICAL RESEARCH, 2002, 19 (11) :1680-1688
[10]  
Dahne L, 2005, [Patent Capsulution Pharma, AG PCT/EP2005/002810], Patent No. 2005002810